BioHealth News Archive
AstraZeneca, Merck & Co. in $8.5-Billion Oncology Collaboration – BioPharm International
AstraZeneca and Merck & Co. announced on July 27, 2017 that they have entered a global strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s…
Read More
Inova accelerator seeks personalized-medicine startups Industries | Virginia Business
The Inova Personalized Health Accelerator (IPHA) is preparing to accept applications from early-stage startups focused on predicting, preventing and treating disease. Falls Church-based Inova…
Read More
Encouraging Life Science Innovation: The Value of Accelerator Programs – Technology Networks
The road to launching a life science start-up can be a long and difficult one, with founders often struggling to secure funding and manage…
Read More
Sucampo: A Shift Toward Rare Diseases – Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) – Seeking Alpha
Sucampo’s (NASDAQ:SCMP) share price has been stuck in a range for a considerable time, but the company wasn’t idle - management has been working…
Read More
Innovation Bridge Breakfast Series @ The Rockville Innovation Center
Tuesday, August 22, 2017 from 8:30 AM to 10:30 AM The MITRE Corporation, BHI, and Montgomery County Economic Development Corporation are pleased to announce…
Read More
Don’t run biomedical science as a business – Nature
As the White House and the US Congress continue to lock horns over President Donald Trump's proposed budget, scientists are once again anxious about…
Read More
Flying Dog Brewery, University of Maryland announce partnership focused on hops production – Baltimore Sun
In the craft-beer industry, the majority of hops — the flowers used in production that add bitterness and aroma to the product — come…
Read More
GSK to streamline research in efficiency drive
GlaxoSmithKline will cut more than 30 drug development programmes and may sell its rare diseases unit, as the FTSE 100 group seeks to inject…
Read More
Mobile Health for Tuberculosis Treatment
The day after emocha® Mobile Health, Inc., launched in 2013, CEO Sebastian Seiguer (pronounced SAY-ger) heard about a 3-year-old tuberculosis (TB) patient being treated…
Read More
The Startling History Behind Merck’s New Cancer Blockbuster
No area is hotter or attracting more dollars in pharma than immuno-oncology–the idea of harnessing the immune system to fight cancer. My fellow Forbes…
Read More
Emergent BioSolutions Secures Exclusive Worldwide Rights to Valneva’s Zika Vaccine Technology – NASDAQ.com
Emergent BioSolutions Inc. (NYSE:EBS) today announced a licensing agreement with Valneva SE for global exclusive rights to Valneva's Zika vaccine technology, ZIKV. Emergent and…
Read More
IonQ Raises $20M Series B Round Led By NEA, GV To Advance Quantum Computing For Commercial
IonQ, an early-stage company developing quantum computing for commercial applications, today announced completion of a $20 million series B round led by New Enterprise…
Read More
A Better Way to Design Clinical Trials | INSEAD Knowledge
A new type of trial design can help the healthcare industry bring beneficial therapies to patients sooner and stop researching inferior ones earlier. Value…
Read More
5th Pediatric Device Symposium – Organized by Sheikh Zayed Institute for Pediatric Surgical Innovation
Calling All Medical Device Innovators! We are now accepting proposals for our annual $250K pediatric medical device pitch competition. Up to six innovations will…
Read More
TO Health!
About the Cluster Action Plan TOHealth! brought together diverse participants from Human Health and Sciences ecosystem in the Toronto region to develop Ontario’s first…
Read More